글로벌 기침 과민증 증후군 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모                              

기침 반사는 흡인에 대한 중요한 보호 메커니즘이지만, 잘못 관리하면 과민해질 수 있습니다. 만성 기침은 실제로 이환율이 높은 심각한 의학적 상태입니다. 기침 과민증 증후군은 이제 통일된 패러다임을 얻었습니다. 만성 기침이 기본 질환과 관계없이 주요 증상인 임상적 실체입니다. 아직 이론이기는 하지만, 새로운 연구에 따르면 비정상적인 신경 생리학이 이 질병의 가장 흔한 원인입니다. 기침 메커니즘에 대한 우리의 이해는 최근 수십 년 동안 이 패러다임의 전환과 함께 발전하여 미래에 더 많은 진전을 이룰 수 있게 되었습니다.

Data Bridge Market Research는 기침 과민증 증후군 시장 이 2021년에 83억 1,000만 달러 규모였으며 2029년까지 131억 5,000만 달러에 도달할 것으로 예상하고 2022년부터 2029년까지의 예측 기간 동안 5.90%의 CAGR을 기록할 것으로 분석했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

시장 정의

WHO에 따르면 기침은 전 세계적으로 가장 흔한 질병입니다. 치료 알고리즘은 소규모 화합물에서 생물학적 및 자연적 치료로 이동하고 있습니다. 최근 몇 년 동안 복합 요법이 점점 더 흔해졌습니다. 업계에서 후원하는 대부분의 제품에 대한 임상 시험이 진행 중입니다. 기침 과민증 증후군은 수면 장애, 구토, 현기증, 심지어 갈비뼈 골절을 포함하여 환자의 삶에 심각한 영향을 미칩니다. 감염, 위식도 역류 질환(GERD), 천식 및 기타 요인이 모두 이에 기여할 수 있습니다. 기침 과민증 증후군 치료 시장의 회사는 신경병성 통증 및 간질 치료를 위한 신경 조절제로 작용하는 GABA 관련 화학 물질인 바바펜틴과 프레가발린의 가용성을 높이고 있습니다. 만성 기침은 신체적 불편함을 더 크게 유발하기 때문입니다. 가바펜틴은 내성 지속성 기침 치료를 위한 위약 대조 시험에서 잘 견디는 것으로 보고되었습니다.

기침 과민증 증후군 시장 동향

운전자

• 만성 호흡기 질환의 유병률 증가

만성 호흡기 질환의 유병률 증가는 기침 과민증 증후군 시장의 성장을 견인할 것으로 예상됩니다. 기침은 전 세계 수백만 명의 사람들에게 영향을 미치는 만연한 질병입니다. 전 세계적으로 만성 호흡기 질환의 유병률이 증가하면서 만성 기침 문제가 증가하고 있습니다. 결과적으로 질병 부담이 확대되면서 글로벌 시장에 밝은 미래가 제공됩니다. 일부 연구에 따르면 천식 , 흡연, 덥고 습한 분위기, 바이러스 또는 박테리아 질병과 같은 다른 요인이 기침 가능성을 높일 수 있다고 합니다.

• 의료 인프라에 대한 투자 증가

Another significant factor influencing the growth rate of cough hypersensitivity syndrome market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics. Healthcare industries are investing in opiates and GABA (gamma-aminobutyric acid)-related substances to help people with cough hypersensitivity. To treat chronic intractable cough, opiates are excellent cough suppressants and have antitussive actions. Similarly, corporations are expanding their tramadol production capabilities, an opioid prescription with a chemical makeup comparable to codeine medicines.

Furthermore, surging geriatric population and sedentary lifestyle of people such as high addiction of smoking will result in the expansion of cough hypersensitivity syndrome market. Along with this, favourable reimbursement policies and rising number of government initiatives to spread awareness will enhance the growth rate of the market.

Opportunities

• Rising number of clinical trials

Over the forecast period, the cough hypersensitivity syndrome market is expected to develop due to an increase in the number of clinical trials for the treatment of cough hypersensitivity syndrome. This is anticipated to boost the new market opportunities. The recent success of a P2X3 receptor antagonist in randomized clinical trials is the first major advancement in cough treatments in 30 years; it finally gives a method for treating persistent cough as well as a useful tool for unravelling the mechanism underlying cough hypersensitivity.

Moreover, the market's growth is fueled by an increase in the number of research and development activities and emerging new markets. These factors will provide beneficial opportunities for the cough hypersensitivity syndrome market growth.

Restraints/Challenges

On the other hand, high cost associated with the treatment will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the cough hypersensitivity syndrome market. Additionally, lack of awareness among people and inefficiency of drugs along with its adverse effects will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This cough hypersensitivity syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cough hypersensitivity syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Cough hypersensitivity syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Cough Hypersensitivity Syndrome Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations had imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The cough hypersensitivity syndrome market was hampered by the supply chain slowness. On the bright side, the cough hypersensitivity syndrome market is likely to improve as respective government bodies lifted the enforced lockdown restrictions. Various sectors are anticipated to rebound quickly post COVID-19 pandemic due to the wide number of applications they serve. As a result, the market is projected to stabilize in the future.

Global Cough Hypersensitivity Syndrome Market Scope

The cough hypersensitivity syndrome market is segmented on the basis of drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Inhales Corticosteroids
• Antitussive Agents
• Short-acting Beta-2 Agonists
• Anticholinergics
• Proton Pump Inhibitors
• Antihistamines
• Others

Route of Administration

• Oral
• Inhalation
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Cough Hypersensitivity Syndrome Market Regional Analysis/Insights

The cough hypersensitivity syndrome market is analyzed and market size insights and trends are provided by country, drug class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the cough hypersensitivity syndrome market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the cough hypersensitivity syndrome market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the high prevalence of respiratory disorders and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, growing focus of major key players on novel technology will further propel the market’s growth rate in this region.

Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to surging number of population in this region. Also, development of healthcare infrastructure and rising government initiatives will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

경쟁 환경 및 기침 과민증 증후군 시장 점유율 분석

기침 과민증 증후군 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 기침 과민증 증후군 시장과 관련된 회사의 초점에만 관련이 있습니다.

기침 과민증 증후군 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Akorn, Incorporated (미국)
• 파이저 주식회사(미국)
• GlaxoSmithKline plc (영국)
• 노바티스 AG(스위스)
• 마일런 NV(미국)
• Teva Pharmaceutical Industries Ltd.(이스라엘)
• 사노피(프랑스)
• 베링거 인겔하임 인터내셔널 GmbH. (독일)
• 아스트라제네카(영국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• Bayer AG(독일)
• 머크앤코(미국)
• Prestige Consumer Healthcare Inc. (미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 브리스톨-마이어스 스퀴브 회사(미국)
• 알미랄, SA(스페인)
• Zenomed Healthcare Private Limited(인도)
• 카딜라 파마슈티컬스(인도)

SKU-53276